08-05-2025 22:07 via medpagetoday.com

Oral IBAT Inhibitor Improves Cholestatic Itch in Primary Biliary Cholangitis

(MedPage Today) -- Linerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients with primary biliary cholangitis (PBC), the randomized phase III GLISTEN trial showed.
Among 238 patients...
Read more »

Medical news



Study: Rheumatology Patients Prefer In-Person Visits
Want to Get Rid of Faulty Race-Based Dx and Treatment Criteria? It Can Be Done.
Mystery Brain Disease in New Brunswick May Not Have Been a Mystery After All
Novel IL-7 Receptor Antagonist Shows Promise in Ulcerative Colitis
FDA OKs First At-Home Test for Cervical Cancer Screening
Biomarker-Informed IBD Therapy Guidance Improved Disease Control
FDA Will Allow Three Color Additives Made From Minerals, Algae, and Flower Petals
Efruxifermin Did Not Reduce Fibrosis in MASH-Related Compensated Cirrhosis
Roflumilast Foam Eases Scalp and Body Psoriasis
Measles Cases Top 1,000: A Crisis of Complacency
Warnings on Budget, Drug Prices; Surveillance for Prostate Cancer; AI Cancer Wins
Exploring the Expanding Role of Surgery in Metastatic Prostate Cancer
MedPod Today: Makary Interview; DEI Order Targets Medical Education; HICPAC Ends
Ventricular Arrhythmias More Likely to Strike Users of Meth, Cocaine
Desktop versie